Stomach Cancer Stage 2 Doctors Abroad — Page 3

Professor Tahsin Ozadli is a specialist medical oncologist at Valued Med Hub Hospitals who focused his research on gastrointestinal malignancies.

• Trained at the Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Expertise in managing gastric and oesophageal cancers within multidisciplinary teams
• Specialises in chemotherapy and targeted systemic treatments for gastrointestinal tumours
• Active researcher with numerous published studies on cancer treatment outcomes
• Focuses on personalized treatment protocols to manage patient side effects effectively

Dr Saban Sec serves as a national representative for the Turkish Medical Oncology Association, leading the way in modern drug therapies for gastrointestinal malignancies.

• Specialises in gastric cancer management using perioperative FLOT chemotherapy protocols
• Research focus on HER2-positive stomach cancer and targeted immunotherapy treatments
• Expert in managing Stage II and III gastrointestinal cases to improve survival rates
• Trained at major teaching hospitals including Haseki and Prof Dr Cemil Tascioglu
• Published international research on metabolic tumour volume and treatment response

Professor Ozcan Yildiz is a senior medical oncologist at Medipol Mega University Hospital with over a decade of documented success in managing complex gastrointestinal tumours.

• Specialises in systemic therapy for stomach cancer, including targeted protocols for stage 2 cases
• Published significant research on gastroenteropancreatic tumours in international medical journals
• Former researcher at Istanbul University's Cerrahpasa Medical Faculty
• Expert in managing paraneoplastic syndromes and rare oncological complications

Associate Professor Yusuf Acikgoz brings high-level expertise to stomach cancer care, having recently served at Ohio State University – one of America's premier cancer research centres.

• Specialised in medical oncology for managing stage 2 stomach cancer via chemotherapy and targeted drugs
• Served as an investigator for the major CheckMate-649 stomach cancer clinical trial
• Expert in immuno-oncology, focusing on how the immune system can be trained to target tumours
• Member of the American Society of Clinical Oncology (ASCO)

Associate Professor Tahsin Ozatli is a specialist oncologist at Istinye University Liv Hospital with a focus on gastrointestinal cancers.

• Specialises in treating cancers of the digestive system, including the stomach and oesophagus
• Holds the academic title of Associate Professor, reflecting a deep engagement with oncological research
• Gained clinical expertise at the Ankara Oncology Clinic, a major Turkish centre for cancer care
• Managed complex cases during his tenure at the Erzurum Regional Training and Research Hospital

Associate Professor Nail Paksoy is an ESMO board-certified medical oncologist at Medipol Bahçelievler University Hospital. He specialises in using modern drug protocols to manage gastrointestinal malignancies.

• Holds prestigious European Society for Medical Oncology (ESMO) certification from Paris
• Published research on the FLOT chemotherapy regimen for gastric cancer cases
• Clinical trial investigator for global pharmaceutical leaders like Roche and Amgen
• Associate Professor at Istanbul Medipol University training the next generation of oncologists
• Completed an intensive medical oncology fellowship at the Istanbul University Oncology Institute

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Professor Ozden is a specialist medical oncologist at VM Medical Park Pendik with dual qualifications in internal medicine and oncology.

• Treats stage 2 stomach cancer using targeted drug therapies and chemotherapy
• Trained at Istanbul University Cerrahpasa – one of the highest-ranked medical schools in the region
• Specialises in medical oncology to manage tumour growth before and after surgery
• Focuses on personalised treatment protocols for digestive system cancers